Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories International Inc CRL
News
-
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River to Perform Plasmid Production for Ship of Theseus
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Charles River Laboratories to Present at Barclays Global Healthcare Conference
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
Investigation Alert Dollar General, Charles River, Acadia Healthcare, and Hawaiian Electric: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call